These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16987080)

  • 1. Cardiac resynchronization treatment of heart failure.
    Hasan A; Abraham WT
    Annu Rev Med; 2007; 58():63-74. PubMed ID: 16987080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical dyssynchrony from the perspective of a cardiac electrophysiologist.
    Beshai JF; Khunnawat C; Lin AC
    Curr Opin Cardiol; 2008 Sep; 23(5):447-51. PubMed ID: 18670255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.
    Ghanbari H; Hassunizadeh B; Machado C
    Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy: overcoming ventricular dyssynchrony in dilated heart failure.
    Kerwin WF; Paz O
    Cardiol Rev; 2003; 11(4):221-39. PubMed ID: 12852801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S30-7. PubMed ID: 12776011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac resynchronization therapy-current status and future perspectives].
    Stellbrink C; Breithardt OA
    Herz; 2003 Nov; 28(7):607-14. PubMed ID: 14689121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac resynchronization therapy with defibrillation capability: considerations on a not yet proven therapeutic superiority].
    Berisso MZ; Canonero D; Caruso D; Setti S; Domenicucci S
    G Ital Cardiol (Rome); 2010 Apr; 11(4):295-305. PubMed ID: 20677575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why should we care about CARE-HF?
    Ellenbogen KA; Wood MA; Klein HU
    J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale behind ventricular resynchronization.
    Parreira L
    Rev Port Cardiol; 2003 Nov; 22(11):1403-18. PubMed ID: 14768495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in heart failure.
    Auricchio A; Fantoni C
    Ital Heart J; 2005 Mar; 6(3):256-60. PubMed ID: 15875517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
    Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in mild heart failure.
    Linde C
    Europace; 2009 Nov; 11 Suppl 5():v72-6. PubMed ID: 19861394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].
    Storti C; Longobardi M; Buzzi MP; Negro MC; Pilun EB; Baldi A; Falcone C
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):123S-128S. PubMed ID: 19195320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.